Category - Alnylam


Meet the Challenge Accepters

It’s not every day that a groundbreaking scientific discovery leads to a potential new class of medicines. But that’s exactly what’s happening at Alnylam. From the “Eureka” moment of discovering RNA interference to the clinical progress and the potential patient impact of the development...

Read More
John Maraganore

John Maraganore

Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam.